Clinical Trial Update: TheraCal LC Coronal Pulpotomy and MTA Coronal Pulpotomy in Mature Permanent Molars [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating TheraCal LC and MTA coronal pulpotomy in mature permanent molars for irreversive pulpitis and deep caries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Caries
• Irreversible Pulpitis

Drugs mentioned

• MTA Coronal Pulpotomy (MTA coronal pulpotomy)
• TheraCal (LC)

Snippet

Sponsor: Postgraduate Institute of Dental Sciences Rohtak | Conditions: Irreversible Pulpitis, Deep Caries | Phase 4 | Status: UNKNOWN